Mulmit

Voyager Therapeutics, Inc.Voyager Therapeutics, Inc.

VYGR Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-3140,374,000-131,844,000-119,721,000-2.04
2024-12-3180,001,000-83,287,000-65,002,000-1.13
2023-12-31250,008,000122,014,000132,330,0002.97
2022-12-3140,907,000-50,837,000-46,408,000-1.21
2021-12-3137,415,000-73,618,000-71,197,000-1.89

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-06-09SCANGOS GEORGE A30,000
2026-06-09MACKEY CATHERINE J30,000
2026-06-09Hyman Steven30,000
2026-06-09Vitale Nancy30,000
2026-06-09Higgins Michael J30,000
2026-06-09Onyia Jude30,000
2026-06-09GERAGHTY JAMES A30,000
2026-06-09Colon Grace30,000
2026-06-09PIERCE GLENN30,000
2026-04-02Sandrock AlfredPresident and CEO11,511
2026-04-01Shiferman Gregory L.SVP and General Counsel50,000
2026-02-24Swartz RobinCOO & CBO6,458

8-K events

FiledItems
2026-08-06Results of operations · Financial statements and exhibits
2026-07-13Other events
2026-06-10Amendments to charter or bylaws · Submission of matters to a vote · Financial statements and exhibits
2026-06-01Other events
2026-05-07Results of operations · Financial statements and exhibits
2026-04-21Officer or director change
2026-03-09Results of operations · Financial statements and exhibits
2026-02-12Officer or director change · Other events
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Biological Products, (No Diagnostic Substances) — 같은 업종, 그리고 규모가 비슷한 기업Biological Products, (No Diagnostic Substances) — and other companies of a similar size

SEC가 같은 업종(Biological Products, (No Diagnostic Substances))으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Biological Products, (No Diagnostic Substances)) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.